. 2020 Jun 10;61(6):381–395. doi: 10.1016/j.hjc.2020.05.004

Table 4.

Frequency of cardiovascular comorbidities, preexisting cardiovascular disease and cardiovascular complications in patients with COVID-19 who recovered the disease.

	n	Median age, years	CV comorbidities			Pre existing CVD	CV complications
	n	Median age, years	Current smoker	HTN	DM	CVD	Myocardial injury	HF	Arrhythmia
Yang⁵³	20^A	51.9^C	10.0	N/A	10.0	10.0	15.0	N/A	N/A
Zhou⁴⁸	137^B	52	4.4	23.4	13.9	1.5^D	0.8	11.7	N/A
Ruan⁵¹	82^B	50	N/A	28.0	15.9	0	6.2^E	N/A	N/A
Shi⁵⁴	40^B	N/A	N/A	N/A	N/A	N/A	5.0	N/A	N/A
Chen⁵⁶	161	51	3.1	24.2	14.3	4.3	16.5	3.2	N/A
Mehra¹⁷⁰	8395^B	48.7^C	5.3	26.4	14.0	10.8^D 1.9^F 3.2^G	N/A	N/A	N/A
Lechien¹⁷¹	264^H	34.1^C	15.9	10.6	1.5	1.9	N/A	N/A	N/A
Shi¹¹⁷	609	61	N/A	26.6	13.1	6.4^D 1.5^I	N/A	N/A	N/A

CV: cardiovascular, CVD: cardiovascular disease, DM: diabetes mellitus, HF: heart failure, HTN: hypertension, n: total recovered patients, N/A: not applicable.

^A Only critically ill patients with COVID-19 were included in the study, ^B Discharged patients, ^C Mean age, ^D Coronary artery disease, ^E Continuous variable representing the median value of cardiac troponin, pg/mL (2.0-28.0), ^F Congestive heart failure, ^G Arrhythmia, ^H Only patients with mild-to-moderate COVID-19 were included in the study, ^I Chronic heart failure.